Medicus Pharma (DB:N46) - Stock Price, News & Analysis

N46 Stock Overview

A biotech/life sciences company, focuses on the development of a drug delivery system using novel dissolvable microneedle arrays for the treatment of certain skin cancers.

About the company

N46 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

Does not have a meaningful market cap (€38M)

Medicus Pharma Ltd. Competitors

Medigene

XTRA:MDG1

€29.8m

4SC

DB:VSC

€57.8m

2invest

XTRA:2INV

€60.4m

co.don

XTRA:CNW

€6.5m

Price History & Performance

Summary of all time highs, changes and price drops for Medicus Pharma
Historical stock prices
Current Share Price	CA$0.57
52 Week High	CA$1.01
52 Week Low	CA$0.57
Beta	0
11 Month Change	0%
3 Month Change	-11.63%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-25.49%

Recent updates

Shareholder Returns

	N46	DE Biotechs	DE Market
7D	0%	-0.7%	1.0%
1Y	n/a	-17.7%	11.2%

Return vs Industry: Insufficient data to determine how N46 performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how N46 performed against the German Market.

Price Volatility

Is N46's price volatile compared to industry and market?
N46 volatility
N46 Average Weekly Movement	n/a
Biotechs Industry Average Movement	6.0%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: N46 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine N46's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2015	n/a	Raza Bokhari	medicuspharma.com

Medicus Pharma Ltd., a biotech/life sciences company, focuses on the development of a drug delivery system using novel dissolvable microneedle arrays for the treatment of certain skin cancers. It intends to develop SkinJect to non-invasively treat basal cell carcinoma of the skin. The company was founded in 2015 and is headquartered in Toronto, Canada.

Medicus Pharma Ltd. Fundamentals Summary

How do Medicus Pharma's earnings and revenue compare to its market cap?
N46 fundamental statistics
Market cap	€25.51m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is N46 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
N46 income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did N46 perform over the long term?

See historical performance and comparison

Medicus Pharma DB:N46 Stock Report